scanX
Home
Narayana Hrudayalaya

Narayana Hrudayalaya

1,854.40
+61.10
(3.41%)
search
Market Cap
37,896.67 Cr
EPS
38.86
PE Ratio
46.76
Dividend Yield
0.22 %
52 Week High
1,833.00
52 Week Low
1,080.00
PB Ratio
11.43
Debt to Equity
0.50
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+87.50 %
+87.50 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+12.50 %
+12.50 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Max Healthcare Institute
1,084.40
#1 1,05,419.08
98.72
5,584.10
18.77
#1 1,058
-17.46
50.46
Apollo Hospitals
7,073.50
1,01,706.08
76.85
#1 19,165.50
14.74
917
49.14
72.63
Fortis Healthcare
664.55
50,170.74
62.15
6,931.20
8.99
645
89.49
54.87
Narayana Hrudayalaya
1,854.40
#4 37,896.67
#1 46.76
#4 5,093.40
#8 10.96
#3 790
#8 2.66
75.88
Global Health
1,269.10
34,086.42
68.71
2,759.20
#1 25.09
326
15.71
57.20
Krishna Institute of Medical Sciences
654.55
26,191.09
74.11
2,511.20
12.94
336
20.76
64.42
Aster DM Healthcare
499.50
24,950.68
95.30
3,723.70
22.85
205
-69.22
67.95
Rainbow Childrens Medicare
1,503.20
15,265.25
64.51
1,334.00
10.76
218
10.06
64.45
Jupiter Life Line Hospital
1,469.40
9,634.27
48.91
1,095.50
21.32
177
20.14
43.38
Healthcare Global Enterprises
593.45
8,273.61
149.62
1,929.10
12.97
41
#1 129.41
72.98
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
365
378
409
400
432
455
492
459
489
526
565
558
653
655
714
735
776
782
829
791
750
398
611
755
846
867
952
967
951
1,041
1,173
1,140
1,236
1,249
1,324
1,222
1,303
1,364
1,424
1,385
Expenses
326
344
360
358
392
402
426
406
425
473
502
502
597
607
640
657
676
675
702
684
659
486
575
648
698
728
774
787
768
842
898
874
946
963
997
925
985
1,037
1,092
1,060
EBITDA
39
34
49
42
40
54
66
53
64
53
63
56
56
49
74
79
101
107
127
107
92
-87
36
107
148
139
179
180
182
200
275
266
290
286
327
297
318
327
332
325
Operating Profit %
10 %
8 %
11 %
10 %
8 %
11 %
13 %
11 %
12 %
9 %
10 %
9 %
8 %
7 %
10 %
10 %
12 %
13 %
15 %
13 %
11 %
-23 %
4 %
14 %
17 %
15 %
18 %
18 %
18 %
19 %
21 %
23 %
23 %
22 %
24 %
23 %
23 %
23 %
22 %
22 %
Depreciation
19
18
18
19
21
19
20
20
21
22
29
24
26
33
34
35
36
41
43
46
55
46
46
47
45
45
46
46
47
48
49
57
56
59
55
63
65
62
65
70
Interest
12
9
8
6
6
6
5
6
6
10
8
8
21
17
18
18
18
22
22
21
21
20
19
19
18
17
17
16
16
15
15
19
21
21
23
25
28
34
35
37
Profit Before Tax
10
10
26
20
13
29
41
28
37
21
26
24
9
-1
22
26
47
43
62
40
16
-153
-30
42
85
77
116
117
119
137
211
190
214
206
248
209
226
232
232
219
Tax
11
11
16
14
8
12
15
11
15
10
10
10
-1
3
8
13
10
13
17
9
4
-34
-26
1
17
1
17
20
50
27
42
36
40
22
22
21
35
30
33
26
Net Profit
-1
-1
10
6
5
17
27
17
22
11
17
14
10
-4
14
13
37
30
45
31
12
-120
-3
41
68
76
99
98
69
111
169
154
173
184
227
188
191
202
199
193
EPS in ₹
0.00
-0.03
0.52
0.29
0.25
0.85
1.31
0.84
1.10
0.54
0.82
0.70
0.48
-0.21
0.67
0.63
1.83
1.49
2.23
1.55
0.59
-5.90
-0.17
2.01
3.35
3.75
4.89
4.80
3.40
5.45
8.31
7.57
8.53
9.06
11.16
9.26
9.39
9.92
9.78
9.50
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
Fixed Assets
913
1,055
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
Current Assets
260
286
302
479
527
586
665
909
1,294
1,946
Capital Work in Progress
20
14
53
35
56
12
20
67
259
514
Investments
0
87
96
9
17
86
120
132
252
844
Other Assets
437
401
416
644
725
701
669
951
1,315
1,615
Total Liabilities
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
Current Liabilities
343
315
323
510
510
602
703
780
987
1,110
Non Current Liabilities
258
365
361
989
1,045
1,153
946
861
1,042
1,629
Total Equity
769
876
963
1,036
1,082
1,137
1,121
1,489
2,132
2,885
Reserve & Surplus
568
674
761
833
878
933
917
1,286
1,928
2,681
Share Capital
200
204
204
204
204
204
204
204
204
204
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
42
28
-22
89
8
-2
59
-4
97
Investing Activities
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
Operating Activities
77
174
219
182
279
443
304
485
1,085
1,067
Financing Activities
140
18
-45
315
-27
-247
-194
-159
88
489
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
11.60 %
0.00 %
10.91 %
10.01 %
9.68 %
9.44 %
DIIs
14.80 %
15.55 %
16.15 %
14.61 %
13.76 %
13.43 %
16.18 %
14.58 %
14.14 %
11.95 %
10.89 %
9.46 %
9.51 %
8.23 %
7.90 %
8.69 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
Public / Retail
4.64 %
4.97 %
4.85 %
5.11 %
5.92 %
6.87 %
5.86 %
6.93 %
7.10 %
7.99 %
8.46 %
9.04 %
10.00 %
11.68 %
12.13 %
11.58 %
Others
16.71 %
15.63 %
15.14 %
16.43 %
16.46 %
15.85 %
14.11 %
14.64 %
14.90 %
16.20 %
5.20 %
17.65 %
5.73 %
6.23 %
6.43 %
6.43 %
No of Share Holders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 0.00 1 2.5 4 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.4 0.25 0.00 0.13 0.19 0.24 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Rumour verification - Regulation 30(11)Apr 08, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 05, 2025
Intimation Regarding Agreement Between The Wholly Owned Subsidiary Of The Company- Narayana Vaishno Devi Specialty Hospitals Private Limited With Shri Mata Vaishnodevi Charitable SocietyMar 28, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Regulation 30_Intimation Regarding The Execution Of Joint Venture Agreement By Health City Cayman Islands A Wholly Owned Subsidiary Of The Company.Mar 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2025
Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 20, 2025
Rumour verification - Regulation 30(11)Feb 18, 2025
Announcement under Regulation 30 (LODR)-AllotmentFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The CompanyFeb 14, 2025
Integrated Filing (Financial)Feb 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2025Feb 14, 2025
Result_Unaudited Financial Result For The Quarter And Nine Month Ended December 31 2024Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024Feb 07, 2025
Intimation Regarding Purchase Of Land At BengaluruFeb 05, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJan 29, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJan 27, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 13, 2025
Report On Investor ComplaintsJan 09, 2025
Intimation Of Grant Of Insurer Certificate Permitting Cayman Integrated Healthcare Ltd. Foreign Step-Down Subsidiary Company To Offer Health Insurance To Residents Of The Cayman IslandsDec 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 12, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 11, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 07, 2024
Announcement under Regulation 30 (LODR)-Scheme of ArrangementNov 29, 2024
Announcement Under Regulation 30 Of SEBI Listing Regulation 2015 - Clarification On News Item Appearing In Mainstream MediaNov 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 13, 2024
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011Nov 13, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 13, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 11, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2024

Technical Indicators

RSI(14)
Neutral
75.88
ATR(14)
Less Volatile
74.63
STOCH(9,6)
Overbought
86.57
STOCH RSI(14)
Overbought
96.50
MACD(12,26)
Bullish
7.92
ADX(14)
Strong Trend
30.59
UO(9)
Bearish
60.78
ROC(12)
Uptrend And Accelerating
10.82
WillR(14)
Overbought
-1.61
Bearish
5
Neutral
1
Bullish
3

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years, 14 days)
Website
https://www.narayanahealth.org
Chairperson NameDEVI PRASAD SHETTY
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.